About
Lanternwick is an independent information resource focused on ibogaine and methadone dependence. We exist to present clear, evidence-first context about a contested topic — emphasizing the limits of current evidence, known safety hazards, and how people can evaluate claims responsibly.
Mission
Lanternwick is an independent resource on ibogaine for methadone dependence, emphasizing evidence limits, serious safety risks, and established treatment options. We aim to help readers assess claims without presenting ibogaine as a proven replacement for methadone care.
What we are not
We are not a clinic, medical provider, or licensed treatment center; our content is not medical or legal advice and does not replace individualized care from qualified professionals.
Our editorial approach
We curate reporting and research to give a clear picture of what is known and what remains uncertain. Our process favors primary sources and official registries where available; we cross-check signals from peer-reviewed literature, clinical registries, and regulatory notices before summarizing findings for readers. For example, we point readers to authoritative registries and reviews rather than republishing case reports without context.
Our pages are organized so readers can find background, a plain-language summary of evidence quality, practical safety considerations, and links to trustworthy external sources. When relevant we also present pointers to established treatment pathways and conventional care options, and we keep a short list of editorial principles that guide content.
To explore the wider site structure and topical pages that we maintain, see our overview on the Lanternwick homepage or review how our services and resources are described on the services page.
What we cover
We publish concise explanations of evidence quality, summaries of peer-reviewed work, and transparent notes on limitations and conflicts. Content is framed for people considering options after methadone treatment and their supporters, with additional material for clinicians and researchers needing a quick orientation.
How we source information
Our fact-checking prioritizes primary literature and established institutions. Where appropriate we cite peer-reviewed journals and regulatory guidance, and we link to public resources such as systematic-reviews or registry listings. For broader claims about pharmacology we may point readers to stable references like the relevant Wikipedia overview (ibogaine — Wikipedia) or to authoritative guidance from medical schools and public-health resources such as the U.S. National Library of Medicine (U.S. National Library of Medicine), which inform our editorial checks.
We also track independent reporting and regulatory statements that affect public safety. For context on clinical trial registries and standards we consult sources like ClinicalTrials.gov when summarizing the state of formal research.
Editorial principles
- Independence — We avoid financial or clinical conflicts that could skew summaries.
- Evidence before hype — Emphasize study design and quality over promotional claims.
- Plain language — Present complex findings in accessible prose.
- Risk transparency — Make safety concerns central to summaries.
We do not provide medical recommendations. For individualized care decisions, readers should consult licensed professionals and established treatment services; our role is to summarise evidence and point to reputable sources.
Who this is for
Our primary audience includes people considering ibogaine after methadone, their supporters, and anyone seeking clear context on benefits, uncertainties, and safety concerns. We also aim to be a starting point for clinicians and researchers who want a compact, well-sourced orientation.
Readers sometimes ask about organizations that provide related services; we link in-context to external directories and discussion sites when they are relevant. For example, community-oriented resources and discussion hubs are occasionally referenced when describing patient experiences, and we include links back to broader site pages where readers can explore services or safety guidance.
Note: a community-curated directory of related practitioners and discussion forums appears elsewhere; one independent directory we reference in editorial pieces is hosted at Ibogaine Basketball.
Independent by design
Lanternwick operates without clinical affiliations so we can present findings without conflicts tied to service provision. Our disclosure is simple: Lanternwick is an independent information resource, not a clinic, medical provider, or licensed treatment center. Our content is not medical or legal advice and does not replace individualized care from qualified professionals.
If you want to explore clinical or peer-reviewed details beyond our summaries, we recommend consulting institutional and government resources. For pharmacology or compound-specific overviews, publicly maintained reference pages such as the U.S. National Library of Medicine provide stable background material (PubMed), while broader encyclopedic context can be found on major educational sites like methadone — Wikipedia.
Final note
If you need resources oriented toward immediate treatment options, our services overview points to how to evaluate care pathways and how information here connects to established treatment choices. For questions about our editorial methods, contact details are available on the contact page.